De forente arabiske emirater - engelsk - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

al ittihad drug store france - powder in a vial (glass) + 100 ml of solvent in a vial (glass) with a stopper (halobutyl) - injection - 1.5 g/100 ml - cardiovascular system-antifibrinolytics , haemostatics

Tanzania - engelsk - Tanzania Medicinces & Medical Devices Authority

atco laboratories limited, pakistan - betamethasone , antibiotics - drops - 105 mg/100ml + 0.525 mg/100ml

De forente arabiske emirater - engelsk - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

100 ml ldpe bottle -

De forente arabiske emirater - engelsk - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

100 ml bag -

De forente arabiske emirater - engelsk - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

alphamed drug store saudi arabia - 100 ml glass bottle - infusion - 400 mg/ 100 ml - musculoskeletal ,joint diseases-rheumatic diseases , gout

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

horizon hospital healthcare pty ltd - levetiracetam -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - epirubicin hydrochloride -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - epirubicin hydrochloride, quantity: 200 mg - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, superficial bladder cancer (tis; ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grades 2 and 3).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - ropivacaine hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sodium chloride - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - fluconazole -